XML 141 R132.htm IDEA: XBRL DOCUMENT v3.22.1
SEGMENT INFORMATION - Revenues by Product Category (Details)
$ in Millions
12 Months Ended
Dec. 31, 2021
USD ($)
product
Dec. 31, 2020
USD ($)
product
Dec. 31, 2019
USD ($)
product
Revenue from External Customer [Line Items]      
Number of products represented of total revenue | product 10 10 10
Revenues $ 8,434 $ 8,027 $ 8,601
Pharmaceuticals      
Revenue from External Customer [Line Items]      
Revenues 3,762 3,680 4,078
Devices      
Revenue from External Customer [Line Items]      
Revenues 1,904 1,566 1,718
OTC      
Revenue from External Customer [Line Items]      
Revenues 1,532 1,430 1,447
Branded and Other Generics      
Revenue from External Customer [Line Items]      
Revenues 1,144 1,248 1,246
Other revenues      
Revenue from External Customer [Line Items]      
Revenues 92 103 112
Bausch + Lomb      
Revenue from External Customer [Line Items]      
Revenues 3,765 3,415 3,778
Bausch + Lomb | Pharmaceuticals      
Revenue from External Customer [Line Items]      
Revenues 514 506 623
Bausch + Lomb | Devices      
Revenue from External Customer [Line Items]      
Revenues 1,596 1,313 1,524
Bausch + Lomb | OTC      
Revenue from External Customer [Line Items]      
Revenues 1,388 1,311 1,322
Bausch + Lomb | Branded and Other Generics      
Revenue from External Customer [Line Items]      
Revenues 240 254 260
Bausch + Lomb | Other revenues      
Revenue from External Customer [Line Items]      
Revenues 27 31 49
Salix      
Revenue from External Customer [Line Items]      
Revenues 2,074 1,904 2,022
Salix | Pharmaceuticals      
Revenue from External Customer [Line Items]      
Revenues 2,066 1,899 2,022
Salix | Devices      
Revenue from External Customer [Line Items]      
Revenues 0 0 0
Salix | OTC      
Revenue from External Customer [Line Items]      
Revenues 0 0 0
Salix | Branded and Other Generics      
Revenue from External Customer [Line Items]      
Revenues 0 0 0
Salix | Other revenues      
Revenue from External Customer [Line Items]      
Revenues 8 5 0
International      
Revenue from External Customer [Line Items]      
Revenues 1,166 1,181 1,154
International | Pharmaceuticals      
Revenue from External Customer [Line Items]      
Revenues 259 255 268
International | Devices      
Revenue from External Customer [Line Items]      
Revenues 0 0 0
International | OTC      
Revenue from External Customer [Line Items]      
Revenues 136 112 119
International | Branded and Other Generics      
Revenue from External Customer [Line Items]      
Revenues 737 775 730
International | Other revenues      
Revenue from External Customer [Line Items]      
Revenues 34 39 37
Solta Medical      
Revenue from External Customer [Line Items]      
Revenues 308 253 194
Solta Medical | Pharmaceuticals      
Revenue from External Customer [Line Items]      
Revenues 0 0 0
Solta Medical | Devices      
Revenue from External Customer [Line Items]      
Revenues 308 253 194
Solta Medical | OTC      
Revenue from External Customer [Line Items]      
Revenues 0 0 0
Solta Medical | Branded and Other Generics      
Revenue from External Customer [Line Items]      
Revenues 0 0 0
Solta Medical | Other revenues      
Revenue from External Customer [Line Items]      
Revenues 0 0 0
Diversified Products      
Revenue from External Customer [Line Items]      
Revenues 1,121 1,274 1,453
Diversified Products | Pharmaceuticals      
Revenue from External Customer [Line Items]      
Revenues 923 1,020 1,165
Diversified Products | Devices      
Revenue from External Customer [Line Items]      
Revenues 0 0 0
Diversified Products | OTC      
Revenue from External Customer [Line Items]      
Revenues 8 7 6
Diversified Products | Branded and Other Generics      
Revenue from External Customer [Line Items]      
Revenues 167 219 256
Diversified Products | Other revenues      
Revenue from External Customer [Line Items]      
Revenues $ 23 $ 28 $ 26
Revenues | Product Concentration Risk | Customer, Top Ten Products      
Revenue from External Customer [Line Items]      
Concentration risk, percentage 43.00% 41.00% 39.00%